In this episode of Boardroom Conversations, Lucas and Luna examine how the Hershey Company's board of directors navigated a hostile takeover threat from Mondelez International in 2016. They break down the unique governance structure of the Hershey Trust Company, which controls 81% of voting power, and explain how the board balanced fiduciary duty with the company's century-old philanthropic mission. Lucas walks through the specific tactics the board used: the poison pill, the appeal to Pennsylvania's attorney general, and the strategic acquisition of Ripple Foods to demonstrate growth potential. Luna challenges whether the board's resistance actually served shareholders, given that Hershey's stock underperformed the S&P 500 over the following five years. The episode uses this single case to explore a broader question: how should a board act when legacy and community responsibility collide with market pressure? Listeners come away understanding the mechanics of a poison pill, the role of a charitable trust in corporate governance, and why 'just saying no' to a premium offer is harder than it looks.

#Hershey #Mondelez #HostileTakeover #BoardOfDirectors #CorporateGovernance #HersheyTrust #PoisonPill #Pennsylvania #MiltonHersheySchool #FiduciaryDuty #ShareholderActivism #MergersAndAcquisitions #RippleFoods #ChocolateIndustry #Business #FexingoBusiness #BusinessPodcast #CorporateStrategy

Keep every episode free: buymeacoffee.com/fexingo

Explore how Novo Nordisk's board navigates the challenge of scaling a blockbuster drug — semaglutide — without losing the company's scientific soul. This episode dives into the unique governance structure that separates the company's charitable foundation from its commercial board, the decision to cap insulin prices at $25 in 2023, and how the board prepared for Ozempic's explosive demand. Lucas and Luna discuss the 'two-tier' system, the tension between patient access and profit, and what other pharma boards can learn from Novo's long-term thinking anchored by its controlling foundation.

#NovoNordisk #BoardGovernance #Pharma #Semaglutide #Ozempic #InsulinPricing #CorporateStrategy #FoundationOwnership #DanishBusiness #Healthcare #LongTermThinking #PatientAccess #BoardroomDynamics #GovernanceStructure #Business #BusinessPodcast #FexingoBusiness #BoardroomConversations

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Boardroom Conversations, Lucas and Luna examine how Ferrari's board has maintained the brand's exclusivity for decades. They dive into the specific governance mechanism—the 'one fewer than demand' production cap—that keeps scarcity high and resale values even higher. They discuss how the board resisted pressure to scale volume after the 2015 IPO, why they said no to a second SUV despite market demand, and how a single board member with deep luxury-goods experience shifted the conversation on brand extensions. The episode also covers the unique governance structure with Ferrari's controlling shareholder Exor, and how the board navigated the transition from Luca Cordero di Montezemolo to Sergio Marchionne to John Elkann. Listeners will learn how a board can treat a brand as a balance-sheet asset and make multi-decade bets on exclusivity over short-term revenue.

#Ferrari #BoardGovernance #BrandExclusivity #LuxuryStrategy #Exor #LucaDiMontezemolo #SergioMarchionne #JohnElkann #IPO #ScarcityStrategy #Business #CorporateLeadership #BoardroomConversations #FexingoBusiness #BusinessPodcast #CEOStrategy #Governance #LuxuryBrands

Keep every episode free: buymeacoffee.com/fexingo

In 2008, Porsche tried to take over Volkswagen using options and debt, briefly becoming the world's most valuable company. The board backed CEO Wendelin Wiedeking's aggressive strategy until it collapsed under $14 billion in debt. This episode examines how Porsche's governance structure enabled and then reined in that ambition — and what it reveals about the risks of a controlling family board. Lucas and Luna walk through the failed put options, the 2008 short squeeze, and the board's decision to merge rather than declare victory.

#Porsche #Volkswagen #WendelinWiedeking #BoardGovernance #CorporateStrategy #TakeoverAttempt #ShortSqueeze #FamilyOwnedBusiness #PiechFamily #PorscheSE #VWGroup #OptionsTrading #DebtCrisis #Business #CorporateGovernance #FexingoBusiness #BoardroomConversations #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Most corporate boards are packed with current CEOs, former bankers, and retired generals. Berkshire Hathaway's board is different: nine directors, average age over 70, almost no financial-services executives, and zero Wall Street alumni. This episode examines how Warren Buffett and Charlie Munger designed a board that doesn't monitor management so much as preserve a specific culture — and what happens when that culture faces its biggest test, succession. We trace the board's evolution from 1970 to today, look at the addition of Greg Abel and Ajit Jain in 2018, and ask whether a board built for Buffett's world can survive in a post-Buffett one.

#BerkshireHathaway #WarrenBuffett #CharlieMunger #BoardOfDirectors #CorporateGovernance #SuccessionPlanning #GregAbel #AjitJain #ValueInvesting #LongTermThinking #BusinessCulture #ShareholderMeeting #CEOTransition #IndependentDirectors #Business #CorporateLeadership #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Episode 19 of Boardroom Conversations digs into how Spotify's board evolved alongside its business model — from a startup in a hostile music industry to a subscription giant with over 500 million users. Lucas and Luna walk through the key structural decisions: why Spotify hired a former Netflix CFO and a gaming executive before most streaming companies had board-level subscription expertise, how the board balances the tension between artist relations and shareholder returns, and the 2021 moment when the board had to decide whether to lean harder into podcasts or defend the music-only moat. They also discuss the role of Daniel Ek as founder-CEO with controlling voting power — and how the board maintains real independence when the founder holds 34% of the votes. If you've ever wondered how a board governs a company that doesn't sell ads, owns no content, and still generates $15 billion in revenue, this one's for you.

#Spotify #DanielEk #BoardGovernance #SubscriptionBusiness #MusicStreaming #PodcastStrategy #FounderLedBoard #CorporateGovernance #StreamingWars #BusinessModel #FexingoBusiness #BusinessPodcast #CEOStrategy #TechLeadership #BoardComposition #IndependentDirectors #ShareholderRights #DualClassStock

Keep every episode free: buymeacoffee.com/fexingo

In 2010, Toyota faced its worst crisis in decades: a recall of over 8 million vehicles due to unintended acceleration, and a board that had grown insular and overconfident. This episode drills into how Toyota's board restructured itself—bringing in outside directors, creating a crisis oversight committee, and embedding quality control into governance. We look at the specific changes: the adoption of a North American-style committee structure, the appointment of outsiders like former GE executive James E. Press, and the creation of a 'Quality Improvement Committee' that reported directly to the board. The result: Toyota rebuilt trust and regained its reputation for reliability within five years. But the real lesson is about how a board can learn from near-failure without abandoning its core principles. We also touch on what other legacy manufacturers can learn from Toyota's governance overhaul. A case study in boardroom humility and strategic renewal.

#Toyota #Boardroom #CorporateGovernance #RecallCrisis #CrisisManagement #QualityControl #BoardRestructuring #OutsideDirectors #JamesPress #ToyotaProductionSystem #BusinessStrategy #Automotive #BusinessPodcast #FexingoBusiness #Leadership #GovernanceReform #ComebackStory #Manufacturing

Keep every episode free: buymeacoffee.com/fexingo

In February 2024, a ransomware attack on UnitedHealth's Change Healthcare subsidiary froze prescription processing and provider payments across the US healthcare system for weeks. The breach ultimately cost the company over $1.6 billion in direct expenses and exposed critical gaps in board-level cyber oversight. This episode examines how UnitedHealth's board — stacked with financial and operational expertise but thin on deep cybersecurity experience — failed to anticipate a threat that had been flagged by regulators years earlier. We walk through the timeline: the 2021 warning from the Cybersecurity and Infrastructure Security Agency about healthcare sector vulnerabilities, the 2022 board risk report that buried cyber risk under 'operational risk', and the post-incident admission that directors had not held a standalone cyber briefing in the eighteen months prior. We also look at what the board changed afterward: appointing a dedicated cyber committee, hiring a former national security official as an independent director, and restructuring executive compensation to include a cybersecurity metric. The episode offers a concrete case study in how board composition can directly determine crisis preparedness — and why 'we have a good IT team' is not a governance strategy.

#UnitedHealth #ChangeHealthcare #BoardOversight #CyberSecurity #CorporateGovernance #Ransomware #Healthcare #RiskManagement #BoardComposition #CISA #CrisisManagement #CyberAttack #Strategy #BusinessPodcast #BoardroomConversations #FexingoBusiness #CorporateLeadership #GovernanceFailure

Keep every episode free: buymeacoffee.com/fexingo

In 2020, Goldman Sachs paid $2.9 billion in penalties for its role in the 1MDB scandal — the largest fine in the bank's history. This episode examines how the board of directors handled the fallout, from ousting CEO Lloyd Blankfein's handpicked successor David Solomon's predecessor to overhauling risk governance. We trace the board's decisions between 2018 and 2022, including the creation of a new Business Standards Committee, the clawback of $174 million in executive compensation, and the structural separation of the investment banking and asset management divisions. Lucas and Luna discuss the tension between preserving Goldman's aggressive revenue culture and satisfying regulators, and what other boards can learn about crisis governance that goes beyond a single scandal.

#GoldmanSachs #1MDB #BoardOfDirectors #CorporateGovernance #CrisisManagement #RiskManagement #WallStreet #DavidSolomon #LloydBlankfein #BusinessStandardsCommittee #RegulatoryFines #Clawback #InvestmentBanking #AssetManagement #Business #Finance #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna examine how the Mayo Clinic's board of trustees governs one of the world's most respected healthcare institutions. The clinic operates as a nonprofit with a unique three-shield model — patient care, research, and education — but still generates over $16 billion in annual revenue. Lucas explains how the board maintains its physician-led culture while making strategic decisions like expanding into Arizona and Florida, launching the Mayo Clinic Platform for data sharing, and navigating the shift to value-based care. Luna asks whether nonprofit boards face weaker accountability than for-profit ones, and Lucas points to the clinic's published community benefit reports and its 'primary value' principle. The hosts dig into the board's composition: 16 trustees, mostly external, with a mix of clinicians, former CEOs, and academics. They also discuss how the board handled the COVID-19 pandemic, including a $1 billion investment in telehealth infrastructure. The episode closes with a question about whether nonprofit healthcare governance is an underappreciated model for other industries.

#MayoClinic #NonprofitGovernance #BoardOfTrustees #HealthcareStrategy #PhysicianLed #ValueBasedCare #Telehealth #CommunityBenefit #ThreeShieldModel #StrategicExpansion #FexingoBusiness #BusinessPodcast #BoardroomConversations #CorporateGovernance #Nonprofit #Healthcare #Leadership #Governance

Keep every episode free: buymeacoffee.com/fexingo